Charm Therapeutics raised $50 million in a Series A funding round co-led by F-Prime Capital and OrbiMed.
05 June 2022
05 June 2022
Total investments received (USD): 130M
Round value (USD): 50M
Company: Charm Therapeutics
Related deals
Chemify raised $50 million Series B round led by Insight Partners and Wing.
Investments
10 October 2025
Comind to raise $60M series B led by Plural, joined by Angelini, LocalGlobe, Octopus Ventures, Crane Venture Partners, BACKED VC and Entrepreneurs First.
Investments
09 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
Investments
01 October 2025
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds
Investments
01 September 2025
Attio raised €44 million Series B round led by GV (Google Ventures), joined by existing investors Redpoint Ventures, 01A, Point Nine, and Balderton Capital.
Investments
10 August 2025
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Sweden
France
Ireland
Portugal